CTRP3 promotes vascular calcification by enhancing phosphate-induced osteogenic transition of VSMC. However, the exact mechanism involved is still unclear. Our study will focus on the effects of transcription coactivator PGC-1α, mitochondria biogenesis and reactive oxygen species (ROS) in CTRP3-promoted VSMC calcification. By using seahorse, immunofluorescence, gene knockdown and overexpression, we will explore the effects of CTRP3 on mitochondria biogenesis and oxidative stress in adenine-induced chronic renal failure rat, arterial ring calcification model and cultured VSMC. We will detect the effects of CTRP3 on mitochondria biogenesis, ROS production, phenotype switch and calcification of VSMC in the presence of βGP, aiming to determine that PGC-1α is the potential target for CTRP3-modulated mitochondria biogenesis, oxidative stress and VSMC calcification, and to clarify the signaling pathway involved in CTRP3-mediated expression and activity of PGC-1α. Our study will reveal the mechanism of CTRP3-mediated mitochondria biogenesis and oxidative stress, provide a new mechanism for CTRP3-promoted VSMC calcification and a potential target for therapeutic interference of vascular calcification.
我们前期的工作发现CTRP3可诱导血管平滑肌细胞(VSMC)向成骨表型转化并促进高磷诱导的VSMC钙化,但具体机制尚不明了。本项目以转录共激活因子PGC-1α为重点,线粒体生物生成和氧化应激为主线,采用线粒体呼吸测定、免疫荧光、基因敲低或过表达等方法在慢性肾衰大鼠、离体血管环和培养的VSMC观察单独CTRP3对线粒体生物生成和氧化应激的调节;CTRP3与高磷共同作用下线粒体生物生成和线粒体呼吸的变化及与VSMC表型转化和钙化的关系,明确PGC-1α是CTRP3调控VSMC线粒体生物生成、氧化应激以及VSMC表型转化和血管钙化的关键调控分子,并揭示CTRP3调控PGC-1α表达和活性的信号通路。我们的研究成果将有助于揭示CTRP3对线粒体生物生成和氧化应激的精细调控,加深对CTRP3促进血管钙化的分子机制的认识,也为临床防治血管钙化提供新的靶点与思路。
补体C1q肿瘤坏死因子相关蛋白3(CTRP3),是新近发现的脂肪因子CTRP家族的成员,在调节炎症和代谢反应中具有重要的作用,但其在心血管系统的保护机制尚不明确。过氧化物酶体增殖物活化受体γ共激活因子-1α(PGC-1α)作为多种核受体及其他转录因子的共激活因子,在线粒体生物生成、氧化磷酸化、肝糖原生成等过程中发挥重要的调节作用。我们在血管平滑肌和心肌细胞上发现,CTRP3增加PGC-1α的表达及活性。使用siRNA敲低PGC-1α的表达,CTRP3上调mtDNA数量以及对ATP合成的促进作用受到抑制,提示PGC-1α是介导CTRP3调控线粒体氧化磷酸化和ATP生成的关键分子,并揭示SIRT1与SIRT3是介导CTRP3调控PGC-1α作用的重要蛋白。在慢性肾疾病(CRF)大鼠钙化的腹主动脉PGC-1α表达降低,在腹主动脉过表达PGC-1α可明显降低CRF大鼠腹主动脉茜素红染色和钙沉积的程度。在原代培养的VSMCs中,过表达PGC-1α明显抑制β-甘油磷酸诱导的VSMCs钙化。这些实验从整体动物、离体器官和细胞水平证实PGC-1α是抑制血管钙化的重要内源性分子。机制研究表明,PGC-1α通过上调SIRT3减少线粒体ROS含量,从而抑制VSMCs由收缩表型向成骨细胞表型转化和血管钙化。我们的研究不仅有助于揭示CTRP3对线粒体生物生成和氧化应激的调控,加深对PGC-1α抑制血管钙化的分子机制的认识,也为临床防治血管钙化提供新的靶点与思路。
{{i.achievement_title}}
数据更新时间:2023-05-31
Protective effect of Schisandra chinensis lignans on hypoxia-induced PC12 cells and signal transduction
Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation
涡度相关技术及其在陆地生态系统通量研究中的应用
祁连山天涝池流域不同植被群落枯落物持水能力及时间动态变化
DeoR家族转录因子PsrB调控黏质沙雷氏菌合成灵菌红素
老龄严重肢体缺血治疗新靶点:mTORC2调控炎症介导的血管生成
骨肉瘤血管生成拟态靶向治疗的新分子靶点初探
心肌肥厚发病机制及其调控新靶点:lncRNAs
心脑血管疾病防治的新靶点:α7受体的研究